Anti-LDL Receptor antibody
| Name | Anti-LDL Receptor antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab30532 |
| Prices | $391.00 |
| Sizes | 75 µg |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | FC IHC-F IHC-P WB ICC/IF |
| Species Reactivities | Mouse, Rat, Human, Pig |
| Antigen | Synthetic peptide: SVADTKGVKRRTL , corresponding to amino acids 499-511 of Mouse LDL Receptor Run BLAST with Run BLAST with |
| Description | Rabbit Polyclonal |
| Gene | LDLR |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
ICC/IF image of ab30532 stained HepG2 cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab30532, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
ab30532 staining LDL receptor in human lung parenchyma.Left panel: with primary antibody at 1 ug/ml. Right panel: isotype control.Sections were stained using an automated system (DAKO Autostainer Plus), at room temperature: sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffers citrate pH6.1. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.
Product References
Silencing diacylglycerol kinase-theta expression reduces steroid hormone - Silencing diacylglycerol kinase-theta expression reduces steroid hormone
Cai K, Lucki NC, Sewer MB. Biochim Biophys Acta. 2014 Apr 4;1841(4):552-62. doi:
Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and - Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and
Yang M, Liu W, Pellicane C, Sahyoun C, Joseph BK, Gallo-Ebert C, Donigan M, Pandya D, Giordano C, Bata A, Nickels JT Jr. J Lipid Res. 2014 Feb;55(2):226-38.
Low density lipoprotein receptor class A repeats are O-glycosylated in linker - Low density lipoprotein receptor class A repeats are O-glycosylated in linker
Pedersen NB, Wang S, Narimatsu Y, Yang Z, Halim A, Schjoldager KT, Madsen TD, Seidah NG, Bennett EP, Levery SB, Clausen H. J Biol Chem. 2014 Jun 20;289(25):17312-24.
Protein phosphatase 2A (PP2A) regulates low density lipoprotein uptake through - Protein phosphatase 2A (PP2A) regulates low density lipoprotein uptake through
Rice LM, Donigan M, Yang M, Liu W, Pandya D, Joseph BK, Sodi V, Gearhart TL, Yip J, Bouchard M, Nickels JT Jr. J Biol Chem. 2014 Jun 13;289(24):17268-79.
Inhibitory action of benzo[alpha]pyrene on hepatic lipoprotein receptors in vitro - Inhibitory action of benzo[alpha]pyrene on hepatic lipoprotein receptors in vitro
Layeghkhavidaki H, Lanhers MC, Akbar S, Gregory-Pauron L, Oster T, Grova N, Appenzeller B, Jasniewski J, Feidt C, Corbier C, Yen FT. PLoS One. 2014 Jul 23;9(7):e102991.
Cholesterol metabolism is altered in Rett syndrome: a study on plasma and primary - Cholesterol metabolism is altered in Rett syndrome: a study on plasma and primary
Segatto M, Trapani L, Di Tunno I, Sticozzi C, Valacchi G, Hayek J, Pallottini V. PLoS One. 2014 Aug 12;9(8):e104834.
Cholesteryl esters accumulate in the heart in a porcine model of ischemia and - Cholesteryl esters accumulate in the heart in a porcine model of ischemia and
Drevinge C, Karlsson LO, Stahlman M, Larsson T, Perman Sundelin J, Grip L, Andersson L, Boren J, Levin MC. PLoS One. 2013 Apr 26;8(4):e61942.
Simvastatin treatment highlights a new role for the isoprenoid/cholesterol - Simvastatin treatment highlights a new role for the isoprenoid/cholesterol
Segatto M, Manduca A, Lecis C, Rosso P, Jozwiak A, Swiezewska E, Moreno S, Trezza V, Pallottini V. Neuropsychopharmacology. 2014 Mar;39(4):841-54.
Influence of genotype on the modulation of gene and protein expression by n-3 - Influence of genotype on the modulation of gene and protein expression by n-3
Boschetti E, Di Nunzio M, Danesi F, Tugnoli V, Bordoni A. Genes Nutr. 2013 Nov;8(6):589-600.
Immunization against proprotein convertase subtilisin-like/kexin type 9 lowers - Immunization against proprotein convertase subtilisin-like/kexin type 9 lowers
Fattori E, Cappelletti M, Lo Surdo P, Calzetta A, Bendtsen C, Ni YG, Pandit S, Sitlani A, Mesiti G, Carfi A, Monaci P. J Lipid Res. 2012 Aug;53(8):1654-61.